← Evidence map

ArticleBMC cancer2021

Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy.

Jie Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

27 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 34126950